Archive: News
-
Genomic Profiling Identifies Patients Most Likely to Respond to Immunotherapy
New discoveries and ongoing research continue to confirm the powerful therapeutic implications of precision medicine for cancer patients. The recent FDA approval of pembrolizumab for patients whose cancers have a specific biomarker is no exception.
Category: News
-
Tumor Mutations: The Upside?
A team of investigators led by researchers at Georgetown Lombardi Comprehensive Cancer Center has found that the tumor mutation load (TML) in a patient’s cancer biopsy varied by age and the type of cancer, along with several other factors. The findings include 14 types of solid tumors and over 8,000 tissue samples, offering one of the most comprehensive analyses of TML to date.
Category: News
-
Deficiencies in DNA Repairing Identified in Tumors
The DNA repair deficiency, called homologous recombination deficiency, or HRD, has previously been studied in only a few cancers, but as researchers at Georgetown Lombardi Comprehensive Cancer Center report, HRD can be found in all of the cancer types the researchers studied, including prostate, breast, pancreatic, and endometrial cancers as well as two of the more deadly types: ovarian cancer and glioma, a type of brain cancer.
Category: News
-
Ultra-personal therapy: Gene tumor boards guide cancer care
Doctors were just guessing a decade ago when they gave Alison Cairnes’ husband a new drug they hoped would shrink his lung tumors. Now she takes it too, but the choice was no guesswork. Sophisticated gene tests suggested it would fight her gastric cancer, and they were right.
Category: News
-
Time to Change the Way We Price Drugs: Value-based pricing, technology assessment among possible solutions
The U.S. should develop a different system of pricing drugs, Peter Bach, MD, said at a forum in Washington, DC on high prescription drug prices hosted by The Atlantic.
Category: News
-
Young Adults Face Steep Increase of Colorectal Cancer Risk
New study shows increased risk of colorectal cancer among young adults as risk among older adults declines.
Category: News
-
Why Is Colorectal Cancer Targeting the Young?
In a special session at the sixth annual Ruesch Center Symposium held in December, experts addressed the disturbing facts about early-onset CRC.
Category: News
-
The Growing Challenge of Young Adults With Colorectal Cancer
In this review, we address specific issues pertaining to AYA patients with colorectal cancer, including evaluation for hereditary colorectal cancer syndromes, clinicopathologic and biologic features unique to AYA patients with colorectal cancer, treatment outcomes, and survivorship.
Category: News
-
The alarming rise in colon cancer among young adults
Dr. Mohamed E. Salem “Good Morning Washington” alongside cancer survivor Julius Grant to share steps you can take to prevent colon cancer.
Category: News
-
Study Finds Sharp Rise in Colon Cancer and Rectal Cancer Rates Among Young Adults
A study led by American Cancer Society researchers finds that new cases of colon cancer and rectal cancer are occurring at an increasing rate among young and middle-aged adults in the US.
Category: News